Open AccessBullous pemphigoid induced by metamizole in a pediatric patient
Author(s) -
İsa An,
Derya Uçmak,
İbrahim İbiloğlu
Publication year - 2018
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_209_17
Subject(s) - medicine , metamizole , etiology , bullous pemphigoid , dermatology , pemphigoid , population , pathology , immunology , environmental health , analgesic , antibody , pharmacology
Bullous pemphigoid (BP) is an autoimmune bullous disease commonly seen in adult population but rarely encountered in the pediatric population. Although the exact etiology of BP remains unclear, various vaccines, infectious agents, and drug use have been blamed in the etiology of BP. Here, we present a 14-year-old patient who developed BP after using metamizole and whose diagnosis was clinically and histopathologically confirmed.